BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Is Mylan Inc. (MYL) Offering Up to $2 Billion for Strides Arcolab Limited Injectables Unit?


2/15/2013 7:26:27 AM

Three highly placed sources have shared that Strides ArcolabBSE -1.30 % and Mylan are in exclusive talks for the deal on Strides' injectables unit, Agila Specialties. Sources have indicated that Mylan's offer is close to $2 billion. The exclusivity period is short-term in nature and the senior officials of Mylan have been visiting India frequently for the negotiations. PfizerBSE -1.15 % had been in advanced talks with Strides Arcolab for the deal at $1.88 billion, but the talks have stalled on valuation mismatch between the buyer and the seller. However, Pfizer and NovartisBSE -0.96 % are still in the fray for the deal.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->